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Abstract 
A sensitive and reproducible fully automated method for the determination of amino acids in plasma based on 
reversed-phase high-performance liquid chromatography and o-phthaldialdehyde pre-column derivatization is
described. A 5-~m Spherisorb ODS 2 column (125 x 3 mm I.D.) was selected for routine determination. Over 40 
physiological amino acids could be determined within 49 rain (injection to injection) and 48 samples could be 
processed unattended. The coefficients of variation for most amino acids in plasma were below 4%. We were also 
able to measure trace amounts of amino acids in plasma normally not detected in a routine analysis. The results 
obtained with the method described compared favourably with those of conventional amino acid analysis 
(r = 0.997) and were in excellent agreement with those of other laboratories (r= 0.999). 
I. Introduction 
Up to now, several methods have been de- 
scribed for the determination of amino acids in 
human plasma using automated o-phthaldial- 
dehyde (OPA) pre-column derivatization and 
high-performance liquid chromatography 
(HPLC) [1-13]. Emphasis has been given to the 
reduced time required for analysis [5,12,13]. This 
is however not the only criterion for a successful 
amino acid analysis. It is also important to 
measure as many plasma amino acids as possible 
occurring with the OPA derivatization method 
with a satisfactory resolution [3,10]. Another 
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problem encountered in most analyses based on 
HPLC using the OPA method is the reliability of 
the measured amino acid concentrations in 
human plasma [4,6,7,13]. This not only depends 
on the choice of the analytical column or the 
derivatization method, but also on the sample 
preparation [7]. 
The purpose of the present study was to 
develop a suitable, sensitive and quick, fully 
automated analysis for the quantitative determi- 
nation of amino acids in plasma and other 
biological materials, by using OPA pre-column 
derivatization and separation by gradient elution 
reversed-phase HPLC. Analytical columns from 
several manufacturers were tested for this pur- 
pose. 
reserved 
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2. Experimental 2.2. Reagents and solvents 
2.1. Equipment 
The HPLC system consisted of an HP 1050 
Series quaternary pump (Hewlett-Packard, 
Waldbronn, Germany), a Model GT-103 on-line 
degassing device (Lab Quatec, Tokyo, Japan) 
and a Mistral column oven with a built-in Peltier 
cooling device (Spark Holland, Emmen, The 
Netherlands). The latter device was necessary in 
order to keep the column temperature exactly at 
25°C. For the automated precolumn derivatiza- 
tion a Model 231-40i Auto-sampling injector 
(Gilson, Villiers-le-Bel, France), equipped with a 
Model 1200 coldblock (Grey Line Engineering, 
MD, USA), and a Rheodyne injection valve 
7010 with a 20-/xl filling loop were used. Fluores- 
cence was monitored with a Model LC-240 
fluorescence detector (Perkin-Elmer, Beacon- 
field, UK) equipped with a xenon discharge lamp 
and a 7-/zl flow cell. Measurements were made at 
an excitation wavelength of 337 nm and an 
emission wavelength of 452 nm with a fixed 
spectral bandpass of 10 nm. Data were collected 
on-line and processed by a PC Integration Pack 
data acquisition system (Kontron Instruments, 
Milan, Italy). 
The following columns were utilized: 
Spherisorb ODS 2, 5 tzm, 150 x 4.6 mm I.D., 
150 x 2 mm I.D. and 150 x 3 mm I.D. (Shandon 
Scientific, Astmoor, U.K.); Hypersil ODS, 5 
/xm, 200 x 2.1 mm I.D. (Hewlett-Packard, Wald- 
bronn, Germany), lnertsil ODS-2, 5 txm, 150 x 
2.1 mm I.D., and Inertsil ODS-80A, 5 txm, 
150 x 4.6 mm I.D. (GL Sciences, Tokyo, Japan); 
Zorbax SB-C18, 3.5/xm, 150 z 4.6 mm I.D., and 
5 /xm, 250 x 3 mm I.D., and Zorbax SB-C8, 5 
/xm, 250 x 4.6 mm I.D. (Rockland Technologies, 
DE, USA); Hypersil Amino Acid, 3 p,m, 150 x 
4.6 mm I.D. (Shandon Scientific, Astmoor, 
UK); Supelcosil LC-18, 5 p,m, 150 z 4 mm I.D. 
(Supelco, Bellefonte, PA, USA); Spherisorb 
ODS 2 cartridge column, 5 /xm and 3 #m, 
125 x 3 mm I.D. (Phase Separations, Queen- 
sferry, UK). All analytical columns were 
protected by a Hypersil ODS guard column, 5 
/zm, 2(1 x 2.1 mm I.D. (Hewlett-Packard, Wald- 
bronn, Germany). 
All solutions were prepared with ultra pure 
water, generated by a Model UHQ-MK II Elgas- 
tat water purification system (Elga, Lane End, 
UK). All chemicals used were of analytical grade 
and the solvents of chromatographic grade. The 
amino acids, including a physiological standard, 
and propionic acid were purchased from Sigma 
(St. Louis, MO, USA). 2-Mercaptoethanol (2- 
ME) was obtained from Fluka (Buchs, Switzer- 
land). All other chemicals and solvents were 
purchased from Merck (Darmstadt, Germany). 
The derivatization reagent was prepared by 
dissolving 50 mg of OPA in 1 ml of methanol, 
adding 9 ml of deoxygenated (30 min bubbling 
with nitrogen) sodium borate buffer (0.2 mol/l, 
pH 10.4), 50 /xl of 2-ME and 50 /xl of Brij 35. 
This reagent was kept in the dark at 4°C and was 
prepared freshly every two weeks. For analysis 
the OPA-reagent was diluted (1:1, v/v) with 
borate buffer and placed in a 0.8 ml amber crimp 
top vial with a silicone rubber, PTFE coated cap 
(Phase Separations). The OPA concentration i  
the reagent was 17 mmol/l. 
Solvents A and B both consisted of disodium 
hydrogen phosphate (250 mmol/1)-propionic 
acid (250 mmol/l)-acetonitrile-tetrahydro- 
furan-water (20:20:7:0.2:51, v/v). The differ- 
ence between the solvents was that prior to the 
addition of acetonitrile, tetrahydrofuran and 
water, the pH of solvent A was adjusted to 6.5 
with 4 M NaOH and the pH of solvent B was 
adjusted to 5.75 with concentrated propionic 
acid. The ultimate pH of solvents A and B 
ranged between 6.72-6.77 and 5.95-6.00, re- 
spectively. The composition of solvent C was 
acetonitrile-methanol-dimethylsulfoxide-water 
(28:24:5:43, v/v). All solvents were filtered 
through a 0.45-tzm filter by suction filtration. 
Amino acid standards were prepared by mix- 
ing the physiological standard (Sigma) with a 
mixture of phosphoserine, asparagine, gluta- 
mine, phosphoethanolamine, hypotaurine, 
homoserine and the internal standard norvaline. 
The final concentration of most amino acids was 
250 p, mol/l, except for phosphoserine, as- 
paragine, pfiosphoethanolamine, L-cystathionine 
and allo-L-cystathionine (125 /~mol/1), hypo- 
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taurine (50 ~zmol/l), tryptophan (TRP, 140-i70 
/xmol/1), and homoserine and norvaline (400 
p~mol/l). The standard prepared in this way was 
diluted (1:1, v/v) with solvent A in order to 
increase the stability of tryptophan and to match 
the peak heights with those in a plasma sample. 
Since the concentration of tryptophan in the 
physiological standard iffered between batches, 
we determined its concentration by means of a 
range of tryptophan concentrations (20-400 
~mol/l) prepared separately. 
2.3. Sample preparation 
Blood (4 ml) was obtained from 44 healthy 
young volunteers (19 men and 25 women; age 
range 28-45 years) and collected in siliconated 
vacutainer tubes containing 0.15% K3-EDTA as 
anticoagulant. Platelet poor plasma was obtained 
by centrifugation at 2650 gmax for 20 min at 20°C 
in a Hettich Rotanta centrifuge and stored at 
-30°C until analysis. In order to check proper 
centrifugation, platelets were always counted in 
the plasma. Before analysis, plasma samples (500 
/~1) were deproteinized with 100/zl of 24% (w/v) 
5-sulphosalicylic acid, containing 2 mmol/l nor- 
valine and homoserine. After immediate vortex- 
mixing and standing for 15 min at 4°C, the 
precipitate was spun down (15 min at 18 400 
gm~×)" Next, 400 pd of the supernatant was 
transferred to a 0.8-ml polypropylene vial and 
was mixed with 100/~1 of 0.3 M LiOH in order 
to adjust the pH to 2.5. 
2.4. Derivatization procedure 
filling loop was loaded with 2 p~l, and 3 s later 
the valve was switched to inject position. After 
each injection cycle the sample loading line was 
flushed with 300 /zl of 10% methanol. The 
volumetric precision obtained with this partial 
loop filling procedure was 0.5-1.5%. 
2.5. Chromatographic conditions 
A ternary solvent system was used. The gra- 
dient program for the Spherisorb ODS 2 car- 
tridge column (5 /xm) is shown in Table 1. The 
flow-rate was maintained at 1.0 ml/min through- 
out and the column temperature was 25°C. 
Typical back pressures ranged from 17-19 MPa 
with solvents A and B to 20-22 MPa with 
solvent C. Total run time (injection to injection) 
was 49 min. For the other columns tested, the 
flow-rate varied between 0.5 and 2.5 ml/min 
(depending on the diameter and particle size), 
the temperature ranged between 25 and 35°C 
and the gradient program was also slightly differ- 
ent. Amino acid derivatives were identified by 
their retention times relative to the reference 
peaks homoserine and norvaline. Quantitation 
was done by measuring peak heights relative to 
the internal standard norvaline. 
2.6. Assay performance 
Quality of the analytical data was assessed by 
assaying plasma samples that had been sup- 
Table 1 
Gradient conditions 
An automated precolumn derivatization pro- 
cedure was employed using the Gilson Auto- 
sampling injector, equipped with a coldblock 
(3°C) and with rack code 31. The following 
program was created: first, aspirate a 5-/~1 air 
bubble into the transferring tube, then aspirate 
20 ~zl of the OPA-reagent, followed by 5 Ixl air 
and 5 jxl of sample or standard. The total volume 
was dispensed into an empty vial and mixed by 
aspirating and dispensing twice. After waiting 6 
s, the total volume was aspirated into the trans- 
ferring tube and the sample loading line was 
flushed with 15 /.H of this mixture. Next, the 
Time B C 
(min) (%) (%) 
0 0 (I 
13.0 0 0 
13.8 0 1.8 
14.0 97.8 2.2 
24.0 90.0 10.0 
26.0 0 13.3 
28.O 0 20 
40.0 0 57 
41.0 0 59 
44.0 0 82 
45.8 0 100 
46.0 0 0 
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plemented with appropriate amino acids. The 
HPLC results were also compared with those 
acquired using an LKB 4400 Amino Acid Ana- 
lyzer with fluorescence detection [14]. Moreover, 
plasma samples were assayed which had been 
analyzed by other laboratories in accordance 
with the terms of the European Quality Assur- 
ance Program. 
3. Results and discussion 
We modified the solvents and gradient used by 
Turnell and Cooper [1], to separate over 40 
amino acids in a plasma-based standard. The 
addition of tetrahydrofuran instead of di- 
methylsulfoxide to the buffered solvents A and 
B, resulted in a better resolution between his- 
tidine and glutamine. Moreover, this resolution 
remained satisfactory for a much longer time. 
Furthermore, we made use of an oven with 
built-in Peltier cooling, resulting in a very stable 
column temperature of 25°C and consequently 
stable retention times. This enabled us to quan- 
tify the amino acid derivatives by measuring 
peak heights, which is more accurate in case of 
unresolved peaks. With the cooled sample-com- 
partment, 48 analyses can be done automatically 
and unattended. 
Of the various columns tested, the best res- 
olution was achieved with both Spherisorb ODS 
2 cartridge columns (3 and 5 /zm, 125 x 3 mm 
I.D.) from Phase Separations, the Spherisorb 
ODS 2 column (5/xm, 150 x 4.6 mm I.D.) from 
Shandon and the Supelcosil LC-18 column (5 
/zm, 150 x 4 mm I.D.) from Supelco. The prob- 
lem with the other columns was that the sepa- 
ration between valine and methionine was un- 
satisfactory, except for the Hypersil-ODS col- 
umn from Hewlett-Packard. However, the latter 
column as well as the Inertsil and Zorbax col- 
umns showed inferior resolution of the cluster of 
amino acids between glycine and hypotaurine. 
The Spherisorb ODS 2 columns from Shandon 
with the smaller diameters also had some prob- 
lems with the resolution between threonine and 
1-methylhistidine and allo-n-cystathionine and 
phenylalanine. Moreover, the resolution of his- 
tidine-glutamine b came worse after some 100 
injections. The Hypersil Amino Acid column 
showed, next to the bad valine-methionine res- 
olution, unsatisfactory separation between 1- 
methylhistidine and arginine. 
We chose the Spherisorb ODS 2 cartridge 
column with 5-/zm particles as the standard 
column, because the other columns did have 
some drawbacks. The Spherisorb ODS 2 car- 
tridge column packed with 3-t~m particles ex- 
hibited extremely high backpressures, 35 MPa 
with 0.85 ml/min solvent C at 25 ° C. For the 
Spherisorb ODS 2 column from Shandon, a 
rather high flow-rate (2.5 ml/min) was necessary 
and the separations between histidine and gluta- 
mine and between arginine and /3-alanine 
became worse after some 200 injections. With 
the Supelcosil LC-18 column, the separations 
between citrulline and 3-methylhistidine and 
between valine and methionine were unsatisfac- 
tory. Moreover, the flow-rate for this column 
(1.9 ml/min) was also higher than for the 
Spherisorb ODS 2 cartridge column (1.0 ml/ 
min). 
An amino acid chromatogram of the standard 
containing 40 amino acids (representative of a 
physiological sample) is shown in Fig. 1. It can 
be seen that, except for carnosine and anserine, 
all amino acids show excellent separation. It is 
also possible with this method to detect arginino- 
succinic acid (retention time 4.5 min), /3-amino- 
butyric acid (retention time 34.0 min and eluting 
between r-aminobutyric acid and tyrosine) and 
diaminobutyric a id (retention time 45.7 min and 
eluting between hydroxylysine and ornlthine). 
However, cysteine, proline and hydroxyproline 
could not be detected with OPA derivatization. 
We did not pretreat our samples with iodoacetic 
acid in order to detect cysteine, because this may 
lead to incorrect values of the more important 
amino acids tyrosine and histidine [15]. On the 
other hand, we added Brij 35 to the derivatizing 
reagent o increase the fluorescence r sponse of 
lysine and hydroxylysine [16]. The problem of 
the instability of the OPA-reagent [6] was solved 
by using multiple amber crimp top vials with a 
silicone rubber, PTFE-coated cap. Each vial was 
used for eight consecutive samples. 
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Fig, 1. Elution profile of an OPA-derivatized physiological amino acid standard (approx. 50 pmol per amino acid). Column: 
Spherisorb ODS 2 (125 × 3 mm I.D.); flow-rate h0 ml/min. For eluents and gradient, see Section 2 and Table 1, respectively. 
Non-standard abbreviations used: Pser = phosphoserine; AAAA = c~-aminoadipic a id; PEA = phosphoethanolamine; H-Ser = 
homoserine; Carn-carnos ine ;  Anser=anser ine;  b-Ala=/3-alanine; Hyptau=hypotaurine; Baiba=/3-aminoisobutyric acid; 
Gaba=r-aminobutyr ic  acid; Aaba=~-aminobutyr ic  a id; ETAM=ethanolamine;  l .S .=internal  standard (=norval ine);  
cystat = cystathionine; allo-cystat = allo-cystathionine; HCys = homocystine; OH-Lys = hydroxylysinc. 
It has to be noticed that there is some batch- 
to-batch variation. This sometimes leads to a bad 
separation between citrulline and carnosine/an- 
serine and between allo-L-cystathionine and 
phenylalanine. However, since we make use of 
peak height determination for the quantitation, 
this is not a serious problem. In the rare cases 
where plasma contains carnosine or anserine, we 
are able to notice this by comparing the peak 
widths of citrulline in the standard and the 
sample. A slight adjustment of the gradient 
condition by changing the time of the start of 
solvent B a few minutes or changing the pH of 
this solvent by 0.03 units, results in a satisfactory 
resolution between citrulline and carnosine/an- 
serine. If the methylhistidines are not fully 
resolved, lowering of the pH of solvent B by 
0.02-0.04 units or starting the gradient with this 
solvent a few minutes earlier, will improve their 
resolution. The resolution between allo-L- 
cystathionine and phenylalanine can be im- 
proved by increasing the percentages of acetoni- 
trile and methanol in solvent C by 2 and 1%, 
respectively. 
The coefficient of variation (C.V.) for the 
retention times was below 0.5% within one batch 
of analyses. The within-run precision was de- 
termined both for the physiological standard and 
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a pooled plasma. The C.V. was for all amino 
acids below 4%. Between-run precision was 
estimated by analyzing 3 aliquots of human 
plasma on 10 different days. The C.V. was for 
most amino acids below 4%, except for 1- 
methylhistidine (13.5%), citrulline (4.4%), 3- 
methylhistidine (27%), taurine (4.4%), fl- 
aminoisobutyric acid (60%), o~-aminobutyric 
acid (5.6%) and methionine (4.6%). 
Under the conditions described, the peak 
heights are linear with concentration up to 1200 
/xmol/l for each amino acid. Concentrations of
amino acids down to 0.5 /xmol/1 in plasma can 
be measured accurately with our method. This 
means that trace amino acids like a-aminoadipic 
acid, phosphoethanolamine, 1- and 3-methylhis- 
tidine, /3-alanine, hypotaurine, /3-amino- 
isobutyric acid, z-aminobutyric acid and 
cystathionine can also be determined. The limit 
of detection depends on the amino acid in 
question, because of different fluorescence re- 
sponses and differing peak shapes of the deriva- 
tives. Typical values were 53 fmol for aspartic 
acid and 167 fmol for serine. 
In Fig. 2, a typical chromatogram of plasma is 
given, showing that 28 physiological amino acids 
could be satisfactory separated, identified and 
quantified. The mean amino acid concentrations 
in plasma from 44 healthy subjects are presented 
in Table 2. The results are in very good agree- 
ment with values obtained by other investigators 
[4,6-8,13,17]. A comparison between our HPLC 
method and the conventional amino acid ana- 
lyzer for the same samples is included in Table 2. 
The HPLC results compared favourably with 
those obtained with the amino acid analyzer. 
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Fig. 2. Chromatogram of human plasma mino acids from a healthy volunteer under identical experimental conditions as in Fig. 
1. For abbreviations see Fig. 1. 
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Table 2 
Amino acid concentrations in plasma from 44 healthy volunteers as determined by HPLC and ion-exchange chromatography 
(values are given in ~mol/ l  as mean + S.D.)  
Amino acid HPLC Ion-exchange '~
Aspartic acid 4.5 ± 2.5 5.4 -+ 3.0 
Glutamic acid 52.0 ± 18.0 36.0 + 12.0 
c~-Aminoadipic acid 0.3 + 0.4 N .D.  h 
Asparagine 54.0 -+ 8.0 58.0 + 14.0 
Serine 104.0 + 16.0 99.0 + 20.0 
Histidine 82.0 + 11.0 92.0 + 13.0 
Glutamine 570.0 ± 69.0 576.0 ± 74.0 
Phosphoethanolamine 2.0 -+ 2.3 1.0 ± 1.4 
Glycine 196.0 ± 42.0 202.0 ± 48./) 
Threonine 137.0 ± 24.0 133.0 ± 33.0 
1-Methylhistidine 5.6 ± 4.2 8.2 + 8.6 
Citrulline 36.0 -+ 7.4 31.0 -+ 6.5 
3-Methylhistidinc 10.3 ± 4.9 7.0 + 5.1 
Arginine 81.0 + 15.0 79.0 + 24.0 
/3 -A lan ine  3.2 ± 2.3 4.1 ± 1.6 
Alanine 379.0 -+ 75.0 399.0 ± 71.0 
Taurinc 46.0 -+ 7.9 50.0 ± 11.0 
/3-Aminoisobutyric acid 4.2 ± 2.5 1.6 ± 1.8 
Tyrosine 67.0 ± 11.0 63.0 ± 19.0 
~x-Aminobutyric acid 24.11 ± 6.4 22.0 ± 6.2 
Ethanolamine 7.0 ± 1.0 11.0 ± 1.8 
Valinc 285.0 -+ 48.0 25l  .0 ± 56.0 
Methionine 29.0 ± 4.6 27.0 ± 6.9 
Tryptophan 57.4 ± 7.2 55.2 ± 9.5 
Phenylalanine 61.0 ± 7.8 55.0 ± 6.9 
l so[euc inc  82.[) ± 16.0 71.0 ± 14.0 
l_.eucinc 142.0 ± 23.0 135.0 ± 24.(/ 
Ornithinc 73.0 ± 15.0 72.0 ± 19.0 
Lys ine 180.0 ± 27.0 171.0 ± 26.0 
" Ion-exchange chromatography was done using an LKB 4400 Amino Acid Analyzer and post-column derivatization with OPA 
1141 
~'N.D. not detected. 
The actual correlation between the two methods 
was highly significant (r = 0.997, p < 0.001). 
The quality of the analytical data was assessed 
by assaying plasma samples that had been sup- 
plemented with known amounts of amino acids 
and by assaying plasma samples in which amino 
acid concentrations had been determined by 
several laboratories. The recovery of each amino 
acid ranged between 96 and 105%, except for 
tryptophan (87%). These values are in accord- 
ance with literature values [7,9,13]. The con- 
centrations of amino acids given in Table 2 have 
all been corrected for recovery. However, one 
may argue that correction for recovery of amino 
acids---except for tryptophan--has any value, 
since concentrations in the physiological amino 
acid standard solutions supplied by Sigma are 
-+4%. 
The results of the quality study are given in 
Table 3. It can be seen that the rare amino acids 
o~ -aminoadipic acid, /3 -alanine, /3 -amino- 
isobutyric acid, ethanolamine and cystathionine 
showed the most deviating values. Nevertheless, 
even when all 30 amino acids were taken into 
account, our mean values were generally in very 
good agreement with the mean and median 
values of other laboratories. Correlation coeffi- 
cients were r = 0.993 and r = 0.996, respectively. 
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Table 3 
HPLC analyses of amino acids in spiked plasma: comparison with other laboratories (results are given in p.mol/l and have not 
been corrected for recovery) 
Amino acid HPLC Other laboratories ~ 
Mean S.D. n Mean Median S.D. n 
Aspartic acid 24.3 0.9 11 24.8 25.0 7.7 511 
Glutamic acid 220.0 0.5 11 233.0 227.0 62.1 521 
c~-Aminoadipic a id 3.3 0.5 8 6.3 4.0 5.4 57 
Asparagine 101.0 1.6 11 111.0 100.0 53.0 460 
Serine 66.2 1.4 11 63.9 63.0 11.9 526 
Histidine 47.2 0.9 11 45.6 45.0 9.6 503 
Glutamine 334.0 11.8 11 322.0 308.0 112.0 505 
Glycine 234.1) 6.2 11 229.0 230.0 33.4 526 
Threonine 249.0 2.2 i 1 235.0 239.0 34.7 536 
1-Methylhistidine 5.8 0.8 6 5.0 5.0 3.0 98 
Citrulline 33.3 1.2 3 38.7 37.0 12.3 498 
3-Methylhistidine 23.2 - 1 21.0 20.0 5.2 388 
Arginine 120.0 2.2 11 119.0 117.0 24.7 521 
/3-Alanine 2.0 0.0 2 5.0 4.0 3.2 26 
Alanine 565.0 6.9 11 551.0 565.0 82.5 538 
Taurine 46.5 2.0 11 49.1 48.0 8.4 481 
/3-Aminoisobutyric a id 2.9 2.4 7 89.7 61.5 93.4 22 
Tyrosine 37.4 0.8 11 38.8 36.0 11.2 531 
c~-Aminobutyric a id 7.4 0.5 11 6.4 5.5 4.4 236 
Ethanolamine 10.7 0.6 3 40.1 29.0 33.1 34 
Valine 261.0 1.8 11 240.0 245.0 40.6 533 
Methionine 44.6 1.4 11 52.4 52.0 12.3 536 
Tryptophan 24.6 0.5 11 25.4 25.0 8.6 227 
Cystathionine 11.8 0.5 4 27.3 12.0 34.5 171 
Phenylalanine 427.0 7.4 11 404.0 405.0 59.2 538 
Isoleucine 64.7 0.5 7 63.7 61.0 17.3 527 
Leucine 226.0 3.1 11 220.0 224.0 39.3 544 
Homocystine 45.0 2.8 3 43.5 45.0 24.6 172 
Ornithine 52.4 1.2 11 53.0 51.0 14.7 517 
Lysine 445.0 11.3 11 427.0 428.0 68.1 531 
a 89 Laboratories participating in the European Quality Assurance Program. 
When /3-aminoisobutyric acid, the amino acid 
with the highest C.V., was excluded, the correla- 
t ion coeff icient reached the high value of r = 
0.999. So, it can be concluded that the results 
obta ined with our HPLC method are in excel lent 
agreement  with those of other laboratories.  
Apar t  f rom the fact that precipitat ion of plas- 
ma proteins with SSA does not result in good 
recovery of  t ryptophan,  the concentrat ions of 
amino acids found with our method are in very 
good agreement  with the l i terature values [4,6- 
8,13,17]. Another  deprotein izat ion method used 
by several investigators, precipitat ion with ace- 
tonitri le in combinat ion with the OPA method,  
does not always result in rel iable values [1-  
3,5,7]. This is probably due to proteolysis and/or  
incomplete xtract ion [5] or to chemical  instabili- 
ty [7]. However ,  it has to be not iced that in these 
studies OPA was used as the der ivat izat ion 
reagent.  When the phenyl isothiocyanate derivati-  
zation method was used in combinat ion with 
acetonitr i le deprotein izat ion,  results obta ined 
were more accurate, a l though C.V. values for 
some amino acids were still rather high [18]. On 
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the other hand, deviating physiological values 
may also result from improper identification of 
amino acids [2,5,18]. 
As many as 250 successive runs could be 
performed with the Spherisorb cartridge column 
without any deterioration of resolution. When 
the separation efficiency decreased, we flushed 
the column with acetonitrile or dichloromethane 
to restore column performance. When this de- 
crease was accompanied by an increase in the 
back-pressure, we also changed the guard col- 
umn. The advantage of using this cartridge 
system is the low cost, and the reusable end- 
fittings make switching of columns both rapid 
and simple. 
Since we can separate over 40 amino acids, 
there is a very small chance that amino acids are 
overestimated, wrongly identified or not iden- 
tified at all. Therefore, our method can also be 
applied to the determination of amino acids in 
serum, urine, cerebrospinal fluid and tissues. An 
example of an amino acid analysis from a urine 
sample is shown in Fig. 3. 
In the literature, only two groups report on an 
assay for amino acids in human plasma capable 
of separating 40 [10] or more [2] amino acids. 
However, the first group [10] did not report 
normal values and their analysis takes 67 min. 
Although the second group [2] was able to 
separate 48 amino acids within 50 min, their 
normal values for most amino acids were far 
below the true physiological values. The three 
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Fig. 3. Elution profile of OPA-derivatized amino acids from adult urine. Chromatographic conditions and non-standard 
abbreviations as in Fig. 1. 
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groups who report on very short analysis times 
[5,12 13] are not able to separate physiological 
trace amino acids like fl-aminoisobutyric acid, 
/3-alanine and cystathionine. Besides, one of 
these groups does not even resolve tryptophan 
and ornithine [5]. 
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